Multiple factors potentially contribute to the progression of cancer in patients with obesity and type 2 diabetes, including hyperinsulinemia and insulin-like growth factor I, hyperglycemia, dyslipidemia, adipokines and cytokines, and the gut microbiome [151]. Here, IGF1 is linked to obesity due to melanocortin 4 receptor deficiency.